What is GHK-Cu studied for?

Published and ongoing research looks at collagen and elastin production in skin models; wound-healing speed and quality; hair-follicle signaling; antioxidant and anti-inflammatory gene expression in cell culture. These are areas of study, not promised outcomes.

Is GHK-Cu FDA-approved?

GHK-Cu has not been evaluated by the FDA. Elevate Chicago lists it for education and research reference only — it is not prescribed as medical care and is not intended for human consumption.

How is GHK-Cu typically used?

Topical formulations are the most common and best-characterized route Discussed in the literature alongside skin-quality and connective-tissue goals Copper status matters — more is not better Any specific dose, frequency or duration comes from a prescription written for you after labs — never from this page.

What are the risks and unknowns with GHK-Cu?

Injectable GHK-Cu is research use only and not FDA-approved Cosmetic topical products are a separate, regulated category Copper accumulation is a real risk with excessive exposure

Repair & recovery

GHK-Cu

Written by the Elevate Clinical Team

Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on August 19, 2026. Independent clinical review pending.

Also known as Copper tripeptide-1

A naturally occurring copper-binding tripeptide studied for collagen synthesis, skin quality and gene-expression effects.

What it is

GHK is a three-amino-acid sequence that binds copper and declines with age. It has been studied for its role in wound healing and, in cell models, for broad effects on the expression of genes involved in tissue remodeling and antioxidant defense. Topical cosmetic use is common and widely available; injectable use is not.

What it's studied for

Collagen and elastin production in skin models
Wound-healing speed and quality
Hair-follicle signaling
Antioxidant and anti-inflammatory gene expression in cell culture

How it's used in practice

Topical formulations are the most common and best-characterized route
Discussed in the literature alongside skin-quality and connective-tissue goals
Copper status matters — more is not better

What you should know before asking about it

Injectable GHK-Cu is research use only and not FDA-approved
Cosmetic topical products are a separate, regulated category
Copper accumulation is a real risk with excessive exposure

Frequently asked questions.

What is GHK-Cu?: GHK is a three-amino-acid sequence that binds copper and declines with age. It has been studied for its role in wound healing and, in cell models, for broad effects on the expression of genes involved in tissue remodeling and antioxidant defense. Topical cosmetic use is common and widely available; injectable use is not.
What is GHK-Cu studied for?: Published and ongoing research looks at collagen and elastin production in skin models; wound-healing speed and quality; hair-follicle signaling; antioxidant and anti-inflammatory gene expression in cell culture. These are areas of study, not promised outcomes.
Is GHK-Cu FDA-approved?: GHK-Cu has not been evaluated by the FDA. Elevate Chicago lists it for education and research reference only — it is not prescribed as medical care and is not intended for human consumption.
How is GHK-Cu typically used?: Topical formulations are the most common and best-characterized route Discussed in the literature alongside skin-quality and connective-tissue goals Copper status matters — more is not better Any specific dose, frequency or duration comes from a prescription written for you after labs — never from this page.
What are the risks and unknowns with GHK-Cu?: Injectable GHK-Cu is research use only and not FDA-approved Cosmetic topical products are a separate, regulated category Copper accumulation is a real risk with excessive exposure

Sources

1.Published literature on GHK-Cu Copper tripeptide-1— PubMed, U.S. National Library of Medicine
2.Compounding and the FDA: questions and answers— U.S. Food & Drug Administration
3.Bulk drug substances nominated for use in compounding under section 503A— U.S. Food & Drug Administration
4.Test directory and patient service center locator— Quest Diagnostics

About this page

Written by the Elevate Clinical Team

Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on August 19, 2026. Independent clinical review pending. Educational content only — not medical advice, not a diagnosis, and not an offer to sell any prescription product.

This page is educational reference material. It is not medical advice, not a diagnosis, and not an offer to sell any product. Prescription therapies are dispensed only through licensed, FDA-registered compounding pharmacies after a physician evaluation. Compounds identified as research use only are not FDA-approved, are not prescribed as medical care, and are not intended for human or animal consumption. Availability, formulations and regulatory status change over time.

Begin your intake Peptide therapy overview